How to Achieve Alignment and Optimal Clinical Trial Supply Forecasting With a Single Source of Truth

A clinical trial usually involves many different parties, who are not always used to communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication can cause misunderstandings if a party is not informed of the latest data, potentially leading to patient risk.

By having a single source of truth, each collaborator can transparently access the latest clinical forecasts as well as up-to-date data including enrollment and dropout rate, titrations probabilities, future productions, etc. The reliability of this information is a must as it plays a fundamental role in the clinical supply strategy, as well as planning including distribution, packaging, manufacturing and sampling.

If everyone agrees on the source of truth, the resulting forecasts can legitimately be used across the organization for resource planning activities, decision-making, vendor management, etc. through strategic visualization dashboards.

When changes occur, such as faster enrollment, batch losses, shipping delays, new countries in the trial, real-time monitoring and updating clinical trial supply forecasts, using real-time data allows the single source of truth to stay current. This enables everyone across the organization to adapt their planning in order to mitigate the unexpected risk, ensuring patients will receive their medication on time while minimizing the costs.

Join this free webinar to learn how to get all clinical trial stakeholders on the same page, using a single source of truth for patient behaviour, demand forecast, production/distribution plans and inventory management.

Speakers

Amaury Jeandrain, Head of Solutions Adoption, Life Sciences, N-SIDE

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain management. After working for a contract research organization (CRO), he joined N-SIDE where he supported the optimization of hundreds of trials from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the extension of N-SIDE’s solutions.

Message Presenter

Pauline Deplasse, Consultant, N-SIDE

Pauline Deplasse joined N-SIDE as a consultant and has since been helping their partners make better and more informed decisions on their clinical trial supply. She has accompanied a growing number of companies in their adoption of N-SIDE’s consulting services and solutions. As a curious problem solver, she thrives in challenging projects. Pauline holds a Master in Business Engineering and has extensive international experience.

Message Presenter